Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Dense Breast Parenchyma clinical trials

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Dense Breast Parenchyma: 2 US clinical trials tracked, none currently recruiting.

Dense Breast Parenchyma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Delphinus Medical Technologies, running 2 of these trials.

Enrollment posture brief

Registry condition dense-breast-parenchyma

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Dense Breast Parenchyma (thi…0%
Open-enrollment share among volume-matched conditions near Dense Breast Parenchyma

Dense Breast Parenchyma has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Dense Breast Parenchyma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Dense Breast Parenchyma is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Dense Breast Parenchyma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Reading of Automated Breast Ultrasound in conjunction with Screening Mammography Device
2 trials

US sites by state

Facility locations filed on Dense Breast Parenchyma trials. A trial with sites in several states counts in each.

Michigan 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Dense Breast Parenchyma page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Dense Breast Parenchyma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Delphinus Medical Technologies sponsors the most Dense Breast Parenchyma trials on record, review their full trial history before evaluating a specific study. See Delphinus Medical Technologies's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dense Breast Parenchyma condition card totals 2 registered trials; most-linked intervention Reading of Automated Breast Ultrasound in conjunction with Screening Mammography; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.